Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Triamcinolone Acetonide in Vitiligo
NCT01766609Phase 2Unknown
- Sponsor
- University of British Columbia
- Start
- Jan 2013
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in Vitiligo, sponsored by University of British Columbia. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT01766609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766609.